COVID-19 Vaccine Types

Inactivated vaccines : 

• Inactivated vaccinations utilize a dead form of the germ that causes the disease.
• Inactivated vaccines do not always generate the same level of immunity (protection) as live immunizations. As a result, you may require repeated dosages over time (booster injections) to maintain immunity.

Vaccines that are live-attenuated: 

• In live vaccines, a weakened (or attenuated) form of the germ that causes a disease is utilized.
• Because these vaccinations are so identical to the natural illness they assist to avoid, they elicit a powerful and long-lasting immune response. Most live vaccinations require just one or two doses to provide lifetime protection against a pathogen and the illness it causes.

Vaccines against messenger RNA (mRNA): 

• For decades, researchers have studied and worked with mRNA vaccines, and this technology was utilized to create several COVID-19 vaccinations. 
• mRNA vaccines generate proteins that stimulate an immune response.
• mRNA vaccines provide various advantages over other forms of vaccinations, including quicker production periods and no chance of producing disease in the person receiving the vaccine because they do not contain a live virus.

Vaccines that are subunit, recombinant, polysaccharide, conjugate: 

• Subunit, recombinant, polysaccharide, and conjugate vaccines use specific germ components like protein, sugar, or capsid (a casing around the germ).
• Because these vaccines only utilize certain portions of the germ, they produce a highly powerful immune response that is unique to critical sections of the germ. 
• They may also be used on practically everyone who requires them, including those with compromised immune systems and long-term health issues.

Vaccines against toxins: 

• Toxoid vaccinations include a toxin (harmful substance) produced by the pathogenic germ. Instead of the germ itself, they develop immunity to the elements of the germ that cause illness. That is, the immune response is aimed toward the toxin rather than the germ as a whole.

Vaccines against viral vectors: 

• For decades, scientists have been exploring viral vector vaccines. Some recent Ebola vaccines employed viral vector technology, and other researchers have focused on viral vector vaccines against other infectious illnesses such as Zika, flu, and HIV. COVID-19 vaccines were also created using this method.

The Indian government-sponsored “Mission COVID Suraksha,” a training program for Indian candidates and researchers working on the COVID-19 vaccine. The government will support the clinical research, production, and licensing of Indian vaccinations to combat the viral attack under this goal. The Mission was designed to be a National Mission to bring to the citizens of the country should be given a safe, effective, economical, and easily available COVID-19 vaccine as soon as possible, with an emphasis on AtmaNirbhar Bharat. The Mission’s purpose is to accelerate the creation of at least 5 to 6 COVID-19 vaccine candidates, with some of these being clinically tested and brought closer to licensing and market debut for regulatory consideration authority, as well as for implementation in public health systems. In this post, we will go over the funds set aside for this mission, as well as the goals and COVID vaccines being produced in India. This is especially significant in light of the approaching Government and Administrative examinations.